Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL MEDICAL CENTRIFUGE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL MEDICAL CENTRIFUGE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL MEDICAL CENTRIFUGE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTLE ANALYSIS
5.2 PORTER’S FIVE FORCES
5.3 KEY STRATEGIC INITIATIVES
5.4 TECHNOLOGICAL ADVANCEMENT IN MEDICAL CENTRIFUGES
5.5 GLOBAL MEDICAL CENTRIFUGE MARKET ANALYSIS (QUALITATIVE AND QUANTITATIVE ANALYSIS)
6 INDUSTRY INSIGHTS
6.1 KEY PRICING STRATEGIES
6.2 INTERVIEWS WITH IMAGING COMPANIES
6.3 INTERVIEWS WITH RADIOLOGISTS
6.4 INTERVIEWS WITH RESEARCH SCHOLARS
6.5 OTHER KOL SNAPSHOTS
7 PATENT ANALYSIS
8 REGULATORY FRAMEWORK
9 GLOBAL MEDICAL CENTRIFUGE MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 CENTRIFUGE
9.2.1 MICROCENTRIFUGE
9.2.1.1. BY TYPE
9.2.1.1.1. REFRIGERATED
9.2.1.1.2. NON-REFRIGERATED
9.2.1.2. BY CAPACITY
9.2.1.2.1. UPTO 10 ML
9.2.1.2.2. MORE THAN 10 ML
9.2.1.3. BY DRIVE SYSTEM
9.2.1.3.1. VARIABLE FREQUENCY MOTOR
9.2.1.3.2. INDUCTION MOTOR DRIVE
9.2.1.4. BY CENTRIFUGE MAX SPEED
9.2.1.4.1. LESS THAN 1000 RPM
9.2.1.4.2. MORE THAN 1000 RPM
9.2.1.5. APPLICATION
9.2.1.5.1. NUCLEIC ACID PURIFICATION
9.2.1.5.2. PCR CLEANUP
9.2.1.5.3. PLASMID MINI-PREP
9.2.1.5.4. PROTEIN PROCESSING
9.2.1.5.5. FORENSICS
9.2.1.5.6. OTHERS
9.2.1.6. END USER
9.2.1.6.1. PHARMACEUTICAL COMPANIES
9.2.1.6.2. BIOTECHNOLOGY COMPANIES
9.2.1.6.3. DIAGNOSTIC LABORATORIES
9.2.1.6.4. ACADEMIC AND RESEARCH INSTITUTES
9.2.2 MEDIUM CAPACITY CENTRIFUGE
9.2.2.1. BY TYPE
9.2.2.1.1. REFRIGERATED
9.2.2.1.2. NON-REFRIGERATED
9.2.2.2. BY CAPACITY
9.2.2.2.1. UPTO 2000 ML
9.2.2.2.2. MORE THAN 2000 ML
9.2.2.3. BY DRIVE SYSTEM
9.2.2.3.1. VARIABLE FREQUENCY MOTOR
9.2.2.3.2. INDUCTION MOTOR DRIVE
9.2.2.4. BY CENTRIFUGE MAX SPEED
9.2.2.4.1. LESS THAN 10000 RPM
9.2.2.4.2. MORE THAN 10000 RPM
9.2.2.5. APPLICATION
9.2.2.5.1. CELL BIOLOGY
9.2.2.5.2. DRUG DISCOVERY
9.2.2.5.3. NANOTECHNOLOGY
9.2.2.5.4. BIOPROCESSING
9.2.2.5.5. BLOOD BANKING
9.2.2.5.6. CLINICAL DIAGNOSTICS
9.2.2.5.7. OTHERS
9.2.2.6. END USER
9.2.2.6.1. PHARMACEUTICAL COMPANIES
9.2.2.6.2. BIOTECHNOLOGY COMPANIES
9.2.2.6.3. DIAGNOSTIC LABORATORIES
9.2.2.6.4. ACADEMIC AND RESEARCH INSTITUTES
9.2.2.6.5. BLOOD BANKS
9.2.3 LARGE CAPACITY CENTRIFUGE
9.2.3.1. BY TYPE
9.2.3.1.1. REFRIGERATED
9.2.3.1.2. NON-REFRIGERATED
9.2.3.2. BY CAPACITY
9.2.3.2.1. UPTO 2000 ML
9.2.3.2.2. MORE THAN 2000 ML
9.2.3.3. BY DRIVE SYSTEM
9.2.3.3.1. VARIABLE FREQUENCY MOTOR
9.2.3.3.2. INDUCTION MOTOR DRIVE
9.2.3.4. BY CENTRIFUGE MAX SPEED
9.2.3.4.1. LESS THAN 10000 RPM
9.2.3.4.2. MORE THAN 10000 RPM
9.2.3.5. APPLICATION
9.2.3.5.1. CELL BIOLOGY
9.2.3.5.2. DRUG DISCOVERY
9.2.3.5.3. NANOTECHNOLOGY
9.2.3.5.4. BLOOD BANKING
9.2.3.5.5. BIOPROCESSING
9.2.3.5.5.1 BIOLOGICS
9.2.3.5.5.2 RECOMBINANT PROTEIN
9.2.3.5.5.3 VACCINES
9.2.3.5.5.4 CELL THERAPIES
9.2.3.5.5.5 VETERINARY MEDICINES
9.2.3.5.5.6 BIOFUELS
9.2.3.5.6. CLINICAL DIAGNOSTICS
9.2.3.5.7. OTHERS
9.2.3.6. END USER
9.2.3.6.1. PHARMACEUTICAL COMPANIES
9.2.3.6.2. BIOTECHNOLOGY COMPANIES
9.2.3.6.3. DIAGNOSTIC LABORATORIES
9.2.3.6.4. ACADEMIC AND RESEARCH INSTITUTES
9.2.3.6.5. BLOOD BANKS
9.3 ACCESSORIES
9.3.1 ROTORS
9.3.1.1. FIXED-ANGLE ROTORS
9.3.1.2. SWINGING-BUCKET ROTORS
9.3.1.3. CONTINUOUS FLOW/ZONAL
9.3.1.4. OTHERS
9.3.2 TUBES
9.3.3 ADAPTERS
9.3.4 BOTTLES
9.3.5 BUCKETS
9.3.6 BLOOD BAGS
9.3.7 WORK STAND
9.3.8 INSTRUMENT VIBRATION MAT
9.3.9 SEALING RINGS
9.3.10 BIOCONTAINMENT LID
9.3.11 BALANCE PLATES
9.3.12 HEPA FILTER
9.3.13 OTHERS
9.4 SOFTWARE
10 GLOBAL MEDICAL CENTRIFUGE MARKET, BY DISPLAY
10.1 OVERVIEW
10.2 TOUCHSCREEN
10.3 ANALOG
11 GLOBAL MEDICAL CENTRIFUGE MARKET, BY MODALITY
11.1 OVERVIEW
11.2 BENCH-TOP
11.3 FLOOR-STANDING
11.4 OTHERS
12 GLOBAL MEDICAL CENTRIFUGE MARKET, BY PORTABILITY
12.1 OVERVIEW
12.2 PORTABLE
12.3 NON-PORTABLE
13 GLOBAL MEDICAL CENTRIFUGE MARKET, BY TEMPARATURE
13.1 OVERVIEW
13.2 REFRIGERATED CENTRIFUGE
13.3 NON-REFRIGERATED CENTRIFUGE
14 GLOBAL MEDICAL CENTRIFUGE MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 DRUG DISCOVERY
14.3 NANOTECHNOLOGY
14.4 CELL BIOLOGY
14.5 BLOOD BANKING
14.6 BIOPROCESSING
14.7 CLINICAL DIAGNOSTICS
14.8 FORENSICS
14.9 OTHERS
15 GLOBAL MEDICAL CENTRIFUGE MARKET, BY END USER
15.1 OVERVIEW
15.2 PHARMACEUTICAL COMPANIES
15.3 BIOTECHNOLOGY COMPANIES
15.4 DIAGNOSTIC LABORATORIES
15.5 HOSPITALS AND CLINICS
15.6 BLOOD BANKS
15.7 ACADEMIC AND RESEARCH INSTITUTES
15.8 OTHERS
16 GLOBAL MEDICAL CENTRIFUGE MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 GLOBAL MEDICAL CENTRIFUGE MARKET, BY REGION
GLOBAL MEDICAL CENTRIFUGE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.1 NORTH AMERICA
17.1.1 U.S.
17.1.2 CANADA
17.1.3 MEXICO
17.2 EUROPE
17.2.1 GERMANY
17.2.2 FRANCE
17.2.3 U.K.
17.2.4 ITALY
17.2.5 SPAIN
17.2.6 RUSSIA
17.2.7 TURKEY
17.2.8 BELGIUM
17.2.9 NETHERLANDS
17.2.10 SWITZERLAND
17.2.11 REST OF EUROPE
17.3 ASIA-PACIFIC
17.3.1 JAPAN
17.3.2 CHINA
17.3.3 SOUTH KOREA
17.3.4 INDIA
17.3.5 AUSTRALIA
17.3.6 SINGAPORE
17.3.7 THAILAND
17.3.8 MALAYSIA
17.3.9 INDONESIA
17.3.10 PHILIPPINES
17.3.11 REST OF ASIA-PACIFIC
17.4 SOUTH AMERICA
17.4.1 BRAZIL
17.4.2 ARGENTINA
17.4.3 COLOMBIA
17.4.4 VENEZUELA
17.4.5 REST OF SOUTH AMERICA
17.5 MIDDLE EAST AND AFRICA
17.5.1 SOUTH AFRICA
17.5.2 SAUDI ARABIA
17.5.3 U.A.E
17.5.4 EGYPT
17.5.5 ISRAEL
17.5.6 REST OF MIDDLE EAST AND AFRICA
17.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
18 GLOBAL MEDICAL CENTRIFUGE MARKET, SWOT AND DBMR ANALYSIS
19 GLOBAL MEDICAL CENTRIFUGE MARKET, COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: GLOBAL
19.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
19.3 COMPANY SHARE ANALYSIS: EUROPE
19.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
19.5 MERGERS & ACQUISITIONS
19.6 NEW PRODUCT DEVELOPMENT & APPROVALS
19.7 EXPANSIONS
19.8 REGULATORY CHANGES
19.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
20 GLOBAL MEDICAL CENTRIFUGE MARKET, COMPANY PROFILE
20.1 THERMO FISHER SCIENTIFIC INC.
20.1.1 COMPANY OVERVIEW
20.1.2 REVENUE ANALYSIS
20.1.3 GEOGRAPHIC PRESENCE
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 SARTORIUS AG
20.2.1 COMPANY OVERVIEW
20.2.2 REVENUE ANALYSIS
20.2.3 GEOGRAPHIC PRESENCE
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 COLE-PARMER INSTRUMENT COMPANY, LLC. (ANTYLIA SCIENTIFIC)
20.3.1 COMPANY OVERVIEW
20.3.2 REVENUE ANALYSIS
20.3.3 GEOGRAPHIC PRESENCE
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENTS
20.4 EPPENDORF SE
20.4.1 COMPANY OVERVIEW
20.4.2 REVENUE ANALYSIS
20.4.3 GEOGRAPHIC PRESENCE
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 QIAGEN
20.5.1 COMPANY OVERVIEW
20.5.2 REVENUE ANALYSIS
20.5.3 GEOGRAPHIC PRESENCE
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ANDREAS HETTICH GMBH & CO. KG
20.6.1 COMPANY OVERVIEW
20.6.2 REVENUE ANALYSIS
20.6.3 GEOGRAPHIC PRESENCE
20.6.4 PRODUCT PORTFOLIO
20.6.5 RECENT DEVELOPMENTS
20.7 DANAHER CORPORATION
20.7.1 COMPANY OVERVIEW
20.7.2 REVENUE ANALYSIS
20.7.3 GEOGRAPHIC PRESENCE
20.7.4 PRODUCT PORTFOLIO
20.7.5 RECENT DEVELOPMENTS
20.8 SIGMA LABORZENTRIFUGEN GMBH
20.8.1 COMPANY OVERVIEW
20.8.2 REVENUE ANALYSIS
20.8.3 GEOGRAPHIC PRESENCE
20.8.4 PRODUCT PORTFOLIO
20.8.5 RECENT DEVELOPMENTS
20.9 HERMLE LABORTECHNIK GMBH (METTLER TOLEDO)
20.9.1 COMPANY OVERVIEW
20.9.2 REVENUE ANALYSIS
20.9.3 GEOGRAPHIC PRESENCE
20.9.4 PRODUCT PORTFOLIO
20.9.5 RECENT DEVELOPMENTS
20.1 NUAIRE, INC. (GENUIT GROUP PLC)
20.10.1 COMPANY OVERVIEW
20.10.2 REVENUE ANALYSIS
20.10.3 GEOGRAPHIC PRESENCE
20.10.4 PRODUCT PORTFOLIO
20.10.5 RECENT DEVELOPMENTS
20.11 BD
20.11.1 COMPANY OVERVIEW
20.11.2 REVENUE ANALYSIS
20.11.3 GEOGRAPHIC PRESENCE
20.11.4 PRODUCT PORTFOLIO
20.11.5 RECENT DEVELOPMENTS
20.12 KUBOTA CORPORATION
20.12.1 COMPANY OVERVIEW
20.12.2 REVENUE ANALYSIS
20.12.3 GEOGRAPHIC PRESENCE
20.12.4 PRODUCT PORTFOLIO
20.12.5 RECENT DEVELOPMENTS
20.13 ACMAS TECHNOLOGIES (P) LTD.
20.13.1 COMPANY OVERVIEW
20.13.2 REVENUE ANALYSIS
20.13.3 GEOGRAPHIC PRESENCE
20.13.4 PRODUCT PORTFOLIO
20.13.5 RECENT DEVELOPMENTS
20.14 ROCH MECHATRONICS INC.
20.14.1 COMPANY OVERVIEW
20.14.2 REVENUE ANALYSIS
20.14.3 GEOGRAPHIC PRESENCE
20.14.4 PRODUCT PORTFOLIO
20.14.5 RECENT DEVELOPMENTS
20.15 JAINCO LAB
20.15.1 COMPANY OVERVIEW
20.15.2 REVENUE ANALYSIS
20.15.3 GEOGRAPHIC PRESENCE
20.15.4 PRODUCT PORTFOLIO
20.15.5 RECENT DEVELOPMENTS
20.16 LABCARE INSTRUMENTS
20.16.1 COMPANY OVERVIEW
20.16.2 REVENUE ANALYSIS
20.16.3 GEOGRAPHIC PRESENCE
20.16.4 PRODUCT PORTFOLIO
20.16.5 RECENT DEVELOPMENTS
20.17 SCILOGEX, LLC
20.17.1 COMPANY OVERVIEW
20.17.2 REVENUE ANALYSIS
20.17.3 GEOGRAPHIC PRESENCE
20.17.4 PRODUCT PORTFOLIO
20.17.5 RECENT DEVELOPMENTS
20.18 DRUCKER DIAGNOSTICS
20.18.1 COMPANY OVERVIEW
20.18.2 REVENUE ANALYSIS
20.18.3 GEOGRAPHIC PRESENCE
20.18.4 PRODUCT PORTFOLIO
20.18.5 RECENT DEVELOPMENTS
20.19 HAIER BIOMEDICAL
20.19.1 COMPANY OVERVIEW
20.19.2 REVENUE ANALYSIS
20.19.3 GEOGRAPHIC PRESENCE
20.19.4 PRODUCT PORTFOLIO
20.19.5 RECENT DEVELOPMENTS
20.2 BENCHMARK SCIENTIFIC, INC.
20.20.1 COMPANY OVERVIEW
20.20.2 REVENUE ANALYSIS
20.20.3 GEOGRAPHIC PRESENCE
20.20.4 PRODUCT PORTFOLIO
20.20.5 RECENT DEVELOPMENTS
21 RELATED REPORTS
22 CONCLUSION
23 QUESTIONNAIRE
24 ABOUT DATA BRIDGE MARKET RESEARCH
